Protagenic Therapeutics Inc
NASDAQ:PTIX
Protagenic Therapeutics Inc
NASDAQ:PTIX
Price:
0.5
USD
-5.66%
Market Closed
Market Cap:
$905k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Protagenic Therapeutics Inc
NASDAQ:PTIX
|
US |
|
A
|
ADVA Optical Networking SE
F:ADV
|
DE |
|
A
|
argenx SE
OTC:ARGNF
|
NL |
|
S
|
St Galler Kantonalbank AG
SIX:SGKN
|
CH |
|
B
|
Bayan Resources Tbk PT
XBER:BNB
|
ID |
|
F
|
Federal National Mortgage Association
XBER:FNM
|
US |
|
G-III Apparel Group Ltd
NASDAQ:GIII
|
US |
|
Sinopharm Group Co Ltd
F:X2S1
|
CN |
|
M&G PLC
OTC:MGPFY
|
UK |
|
Prysmian SpA
F:AEU
|
IT |
|
Barrick Gold Corp
TSX:ABX
|
CA |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of PTIX.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PTIX
Multiples-Based Value
Not Available
